Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — Cardlytics, Inc.

Accession: 0001628280-26-061459

Filed: 2026-09-11

Period: 2026-09-04

CIK: 0001666071

SIC: 7370 (SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.)

Item: Entry into a Material Definitive Agreement

Item: Financial Statements and Exhibits

Documents

8-K — cdlx-20260904.htm (Primary)

EX-10.1 (jainvcardlytics-20260904se.htm)

GRAPHIC (cdlx-20260904_g1.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: cdlx-20260904.htm · Sequence: 1

cdlx-20260904

0001666071false00016660712026-09-042026-09-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 4, 2026

CARDLYTICS, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware 001-38386 26-3039436

(State or other jurisdiction of

incorporation or organization) (Commission

File Number) (I.R.S. Employer

Identification No.)

675 Ponce de Leon Avenue NE, Suite 4100 Atlanta Georgia 30308

(Address of principal executive offices, including zip code)

(888) 798-5802

(Registrant's telephone, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each class Trading symbol Name of each exchange on which registered

Common Stock CDLX The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 1.01. Entry into a Material Definitive Agreement

As previously disclosed in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026 (the “Q2 2026 Form 10-Q”), in connection with the acquisition of Bridg, Inc. (“Bridg”) by Cardlytics, Inc. (the “Company”) in 2021, the Company assumed certain indemnification obligations to former officers and directors of Bridg pursuant to existing indemnification agreements.

On July 9, 2026, Amit Jain, the founder and former Chief Executive Officer and director of Bridg, filed a verified complaint against the Company in the Court of Chancery of the State of Delaware (Case No. 2026-0896-TJF) seeking advancement and indemnification for fees and expenses incurred in connection with (i) the action captioned DailyGobble, Inc. v. Amit Jain, et al., No. 22STCV15317, in the Superior Court of the State of California (the “DailyGobble Action”), which was resolved through a settlement under which Mr. Jain’s allocated portion was approximately $5.3 million, and (ii) related insurance coverage actions involving Scottsdale Insurance Company.

On September 4, 2026, the Company and Mr. Jain entered into a settlement and release agreement (the “Settlement Agreement”), pursuant to which the parties agreed to settle Mr. Jain’s claim for an aggregate amount of $6.4 million, consisting of Mr. Jain’s allocated portion of the DailyGobble Action settlement and associated costs, plus $1.1 million in satisfaction of legal fees incurred related to the DailyGobble Action. This aggregate settlement amount is consistent with the $6.5 million accrual (comprised of a $5.3 million accrual for the settlement and a $1.2 million accrual for attorney's fees) recorded by the Company as of June 30, 2026, as disclosed in the Q2 2026 Form 10-Q. To recoup some of these costs, the Company is seeking insurance reimbursement that it believes should apply to this matter.

The foregoing description of the Settlement Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Settlement Agreement, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits

(d)    Exhibits

Exhibit    Exhibit Description

10.1*

Settlement Agreement, dated as of September 4, 2026, by and between Cardlytics, Inc. and Amit Jain.*

104 The cover page from Cardlytics, Inc.’s Form 8-K filed on September 11, 2026, formatted in Inline XBRL

* Pursuant to Item 601(a)(5) of Regulation S-K promulgated by the SEC, certain exhibits and schedules to the Settlement Agreement have been omitted. The Company hereby agrees to furnish supplementally to the SEC, upon its request, any or all of such omitted exhibits or schedules.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Cardlytics, Inc.

Date: September 11, 2026 By: /s/ David Evans

David Evans

Chief Financial Officer

(Principal Financial and Accounting Officer)

EX-10.1

EX-10.1

Filename: jainvcardlytics-20260904se.htm · Sequence: 2

Document

Exhibit 10.1

CONFIDENTIAL SETTLEMENT AGREEMENT

This Confidential Settlement Agreement (the “Agreement”), dated September 4, 2026 is entered into by and among Cardlytics, Inc. (“Cardlytics”) and Amit Jain (“Mr. Jain”). Cardlytics and Mr. Jain shall each be referred to herein as a “Settling Party,” and collectively as the “Settling Parties.”

WHEREAS, on November 20, 2014, Bridg, Inc. (“Bridg”) entered into a Director Indemnification Agreement with Mr. Jain (the “Indemnification Agreement”);

WHEREAS, on April 12, 2021, Cardlytics executed an Agreement and Plan of Merger with Bridg (the “Merger Agreement”), pursuant to which Cardlytics acquired Bridg by merger and assumed all of Bridg’s obligations under the Indemnification Agreement, including pursuant to Section 4.5 of the Merger Agreement;

WHEREAS, DailyGobble, Inc. filed a lawsuit against Mr. Jain and others captioned DailyGobble, Inc. v. Amit Jain, et al., No. 22STCV15317, in the Superior Court of the State of California (the “DailyGobble Action”);

WHEREAS, Scottsdale Insurance Company filed a declaratory judgment action captioned Scottsdale Insurance Co. v. Amit Jain, C.A. 2:24-cv-09352 (C.D. Cal.), and Mr. Jain filed a separate action captioned Jain v. Scottsdale Insurance Co., C.A. 2:26-cv-03524 (D. Del.) (collectively, the “Scottsdale Actions”);

WHEREAS, the subject matter of the Scottsdale Actions concerns the availability of director and officer insurance coverage for Mr. Jain’s expenses and settlement of the DailyGobble Action;

WHEREAS, the DailyGobble Action was resolved through settlement, under which Mr. Jain’s portion of the settlement was Five Million Two Hundred Fifty Thousand Dollars ($5,250,000) (the “DailyGobble Settlement”);

WHEREAS, in connection with the DailyGobble Action and the Scottsdale Actions, Mr. Jain has been represented by: Cooley LLP (“Cooley”), Michelman & Robinson, LLP (“Michelman”), Cohen Ziffer Frenchman & McKenna LLP (“Cohen Ziffer”), Weil, Gotshal & Manges LLP (“Weil”), and Potter Anderson & Corroon LLP (“Potter Anderson”);

WHEREAS, Mr. Jain has asserted claims against Cardlytics in Amit Jain v. Cardlytics, Inc. (Case No. 2026-0896-TJF) (the “Delaware Action”) seeking advancement and indemnification for expenses related to the DailyGobble Action and the Scottsdale Actions;

WHEREAS, since the Delaware Action was filed on July 9, 2026, Cardlytics has received invoices from Mr. Jain for Skadden, Arps, Slate, Meagher & Flom LLP (“Skadden”), Cohen Ziffer, Potter Anderson, Cooley, and Weil, the amounts of which are set forth in the schedule attached hereto as Exhibit A, and has initiated payment via wire transfer to Mr. Jain or directly to those firms, as applicable; and

WHEREAS, the Settling Parties have determined that it is in their respective best interests to resolve, settle and compromise the claims in the Delaware Action.

NOW, THEREFORE, intending to be legally bound, and in consideration of the agreements set forth in this Agreement, the Settling Parties agree as follows:

1.Settlement Payment.

1.1.On or before September 4, 2026, Cardlytics shall initiate payment via wire transfer of the aggregate sum of $6,441,649.40, paid in total to Mr. Jain pursuant to payment instructions attached hereto as Exhibit B, consisting of (a) Five Million Two Hundred Fifty Thousand Dollars ($5,250,000) representing Mr. Jain’s portion of the DailyGobble Settlement and associated borrowing costs of fifty-one thousand, six hundred sixty-three dollars and sixty cents ($51,663.60), plus (b) one million, one hundred thirty nine thousand, nine hundred eighty five dollars and eighty cents ($1,139,985.80) in satisfaction of Cardlytics’s obligation to pay Michelman’s fees incurred in representing Mr. Jain up to the date of this Agreement.

1.2.Cardlytics agrees to advance Mr. Jain’s reasonable attorneys’ fees and costs incurred in connection with the Scottsdale Actions and Delaware Action that have accrued through the date of this Agreement, pursuant to and in accordance with the terms of the Indemnification Agreement. Further, Cardlytics agrees to advance Mr. Jain’s reasonable attorneys’ fees and costs in connection with the Scottsdale Actions, Delaware Action, and the settlement of the DailyGobble Action on a going-forward basis, if any, pursuant to and in accordance with the terms of the Indemnification Agreement and the Fitracks order in the Delaware Action.

2.Assignment of Scottsdale Actions.

2.1.     As of the date of this Agreement, Mr. Jain agrees to irrevocably assign, transfer, and convey to Cardlytics all of his right, title, and interest in and to the Scottsdale Actions, except as set forth in Section 2.2 below, including without limitation: (a) all claims, causes of action, counterclaims, and defenses asserted or assertable therein; (b) all rights to prosecute, settle, dismiss, or otherwise resolve the Scottsdale Actions; (c) all rights to any judgment, award, recovery, or settlement proceeds from the Scottsdale Actions; and (d) all attorney-client privileges, work product protections, and other litigation privileges associated with the Scottsdale Actions, to the extent transferable. Mr. Jain agrees to execute such further documents and take such further actions as Cardlytics may reasonably request to effectuate this assignment, including making any filings in the Scottsdale Action to substitute parties or counsel. As of the date of this Agreement, Cardlytics shall have sole authority to direct the conduct of the Scottsdale Actions, and Mr. Jain shall cooperate reasonably with Cardlytics in connection therewith, exclusively at Cardlytics’s expense, pursuant to and in accordance with the Indemnification Agreement and relevant insurance contracts. For the avoidance of doubt, Mr. Jain shall have the right to retain independent legal counsel of his own choosing if required for his cooperation, the reasonable fees and expenses of which shall be borne exclusively by Cardlytics. In the event that Cardlytics fails or refuses to pay such fees and expenses, Mr. Jain shall have no obligation to cooperate with Cardlytics pursuant to this paragraph until such time as Cardlytics satisfies its payment obligations hereunder. In connection with this assignment, Mr. Jain represents and warrants that

he has not previously assigned, pledged, or otherwise encumbered any interest in the Scottsdale Actions or the related insurance contracts, and that he has full authority to make this assignment.

2.2.    Notwithstanding the foregoing, Mr. Jain’s claims for breach of the implied covenant of good faith and fair dealing asserted in the Scottsdale Actions (the “Implied Covenant Claims”) are expressly excluded from this assignment and shall be retained by Mr. Jain. Mr. Jain agrees that, promptly following the effective assignment of the Scottsdale Actions to Cardlytics pursuant to Section 2.1, he shall dismiss the Implied Covenant Claims.

3.Dismissal of the Delaware Action.

3.1.Within two (2) business days of receipt by Mr. Jain of the settlement payment described in Section 1.1, the Settling Parties shall execute and Mr. Jain shall file in the Delaware Action the Stipulation and [Proposed] Order of Dismissal with Prejudice attached hereto as Exhibit C. The Dismissal with Prejudice filed in the Delaware Action will not preclude Mr. Jain from enforcing his rights to advancement or indemnification under the Indemnification Agreement or Delaware law for anything related to his cooperation in the Scottsdale Actions or the Fitracks order for fees and costs accrued pursuant to Section 1.2.

4.     Mutual Releases.

4.1.     Effective upon Cardlytics’s payment of the amount set forth in Section 1.1, Mr. Jain, on behalf of himself and his heirs, executors, administrators, successors, and assigns, hereby irrevocably and unconditionally releases, acquits, and forever discharges Cardlytics, and its current and former officers, directors, employees, agents, affiliates, subsidiaries, parents, successors, and assigns (collectively, the “Cardlytics Released Parties”), from any and all claims, demands, actions, causes of action, damages, liabilities, judgments, liens, costs, expenses, and attorneys’ fees of any kind or nature whatsoever, whether known or unknown, suspected or unsuspected, asserted or unasserted, contingent or non-contingent, that Mr. Jain ever had, now has, or may hereafter have against the Cardlytics Released Parties, arising out of or related to the DailyGobble Action, the Scottsdale Actions, or the Delaware Action, including but not limited to any claims for advancement, indemnification, or fees-on-fees under the Indemnification Agreement related to the DailyGobble Action, the Scottsdale Actions, or the Delaware Action; provided, however, that this release shall not apply to (a) fees and costs in Section 1.2, (b) any claims for advancement or indemnification in the Scottsdale Actions and Delaware Action on a going-forward basis, if any, pursuant to and in accordance with the terms of the Indemnification Agreement and the Fitracks order in the Delaware Action; (c) any claims to enforce the terms of this Agreement, or (d) any rights to advancement or indemnification under the Indemnification Agreement or Delaware law with respect to any future proceedings that are unknown and do not exist as of the date of this Agreement.

4.2.    Effective upon Mr. Jain’s dismissal of the Delaware Action pursuant to Section 3.1, Cardlytics, on behalf of itself and its affiliates, subsidiaries, parents, successors, and assigns, hereby irrevocably and unconditionally releases, acquits, and forever discharges Mr. Jain, and his heirs, executors, administrators, successors, and assigns (collectively, the “Mr. Jain Released Parties”), from any and all claims, demands, actions, causes of action, damages, liabilities, judgments, liens, costs, expenses, and attorneys’ fees of any kind or nature whatsoever, whether known or unknown, suspected or unsuspected, asserted or unasserted, contingent or non-

contingent, that Cardlytics ever had, now has, or may hereafter have against the Mr. Jain Released Parties, arising out of or related to the Delaware Action, the DailyGobble Action, or the Scottsdale Actions; provided, however, that this release shall not apply to (a) any claims made by Mr. Jain for advancement or indemnification in the Delaware Action on a going-forward basis, if any, pursuant to and in accordance with the terms of the Indemnification Agreement and the Fitracks order in the Delaware Action, or (b) any claims to enforce the terms of this Agreement. For the avoidance of doubt, Cardlytics will not attempt to clawback anything paid pursuant to the Indemnification Agreement.

4.3.    Except as expressly set forth above, all rights under Section 1542 of the Civil Code of the State of California, and under any and all similar laws of any governmental entity, including without limitation, the federal and state governments in any country in the world, are hereby expressly waived in connection with the releases given in Paragraphs 4.1 and 4.2 above. The Settling Parties are each aware that said Section 1542 of the California Civil Code provides as follows:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.

The Settling Parties acknowledge that they may hereafter discover theories of liability or facts in addition to or different from those which they now know or believe to be true with respect to the subject matter of the releases, but that it is their intention to fully and finally settle and release any and all claims released hereby, known or unknown, suspected or unsuspected, contingent or non-contingent, whether or not concealed or hidden, which now exist, or heretofore have existed upon any theory of law or equity now existing or coming into existence in the future, including, but not limited to, conduct which is negligent, intentional, with or without malice, or a breach of any duty, law or rule, without regard to the subsequent discovery or existence of such different or additional facts.

5.General Provisions.

5.1.    The Settling Parties hereby agree to keep the terms of this Agreement confidential, except that this Agreement and its terms may be disclosed as necessary to the courts in the Delaware Action and the Scottsdale Actions, counsel, accountants, lenders, creditors, auditors, insurers, and regulators of the Settling Parties, or as otherwise required by law. If any Settling Party receives legal process that purports to require disclosure of the terms of this Agreement, the Settling Party receiving such process will resist it to the extent this may be done lawfully and in good faith and, within three (3) business days of receipt of the legal process or, if earlier, before responding to it, will notify the other Settling Party of service of same, unless prohibited by law from doing so.

5.2.    This Agreement may be executed in several counterparts, and all counterparts so executed shall together be deemed to constitute one complete agreement, and each such counterpart shall be deemed to be an original, binding the Settling Party subscribed thereto. This

Agreement may be executed by facsimile, photo or electronic signature and such facsimile, photo or electronic signature shall constitute an original for all purposes.

5.3.    This Agreement constitutes the final and complete agreement of the Settling Parties with respect to the matters covered by this Agreement and supersedes any prior written or oral understandings between the Settling Parties with respect to the matters covered by this Agreement.

5.4.    This Agreement may not be altered, modified, or amended, unless by agreement in writing executed by the Settling Parties hereto or their authorized representatives, nor any of its provisions waived, unless in writing by the Settling Party granting such waiver.

5.5.    Any dispute, claim or controversy arising out of or relating to this Agreement shall be governed by and interpreted, construed, and determined in accordance with the internal laws of the State of Delaware, without regard to its conflicts of law principles and the Settling Parties each agree to submit any such disputes exclusively to the Court of Chancery of the State of Delaware.

5.6.    This Agreement shall be deemed to have been jointly drafted and no provision of it shall be interpreted or construed for or against any Settling Party because such Settling Party purportedly prepared or requested such provision, any other provision, or this Agreement as a whole.

5.7.    The Settling Parties agree to cooperate fully and to execute any and all additional documents and take any and all additional actions as may be necessary and appropriate to give full force and effect to the terms and intent of this Agreement.

5.8.    Any provision of this Agreement which is invalid, illegal, or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective solely to the extent of such invalidity, illegality, or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal, or unenforceable in any other jurisdiction.

5.9.    Each Settling Party irrevocably binds itself and each of its current or former predecessors, partners, members, parents, subsidiaries, affiliates, directors, officers, employees, successors, assigns, heirs, legatees, executors, administrators, representatives, agents, insurers, attorneys and privies.

5.10.    Any notices required to be sent to Cardlytics under this Agreement, including for service of any lawsuit to enforce this Agreement, shall be sent via email to:

Robert R. Long ([ ])

CC: Cardlytics Legal Department ([ ])

5.11 Any notices required to be sent to Mr. Jain under this Agreement, including for service of any lawsuit to enforce this Agreement, shall be sent via email to:

Jenness E. Parker ([ ])

IN WITNESS WHEREOF, the Settling Parties have caused this Agreement to be duly executed on the date first written above.

Cardlytics, Inc.

/s/ David Evans /s/ Jenness E. Parker

By: David Evans SKADDEN, ARPS, SLATE,

Title: Chief Financial Officer MEAGHER & FLOM LLP

Jenness E. Parker (ID No. 4659)

Lauren N. Rosenello (ID No. 5581)

Eric M. Holleran (ID No. 6824)

Brandon D. Walker (ID No. 7279)

One Rodney Square

P.O. Box 636

Wilmington, Delaware 19899-0636

[ ]

Attorneys for Plaintiff Amit Jain

Exhibit A

Invoice Amounts Received by Cardlytics Since July 9, 2026

Exhibit B

Payment Instructions

Exhibit C

Stipulation and [Proposed] Order of Dismissal with Prejudice

GRAPHIC

GRAPHIC

Filename: cdlx-20260904_g1.jpg · Sequence: 7

Binary file (26710 bytes)

Download cdlx-20260904_g1.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.1

Document and Entity Information

Sep. 04, 2026

Entity Information [Line Items]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 04, 2026

Entity Registrant Name

CARDLYTICS, INC.

Entity Central Index Key

0001666071

Entity Incorporation, State or Country Code

DE

Entity File Number

001-38386

Entity Tax Identification Number

26-3039436

Entity Address, Address Line One

675 Ponce de Leon Avenue NE, Suite 4100

Entity Address, City or Town

Atlanta

Entity Address, State or Province

GA

Entity Address, Postal Zip Code

30308

City Area Code

(888)

Local Phone Number

798-5802

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Title of 12(b) Security

Common Stock

Security Exchange Name

NASDAQ

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Entity Registrant Name

CDLX

X

- Definition

Title of 12(b) Security

+ References

No definition available.

+ Details

Name:

cdlx_Titleof12bSecurity

Namespace Prefix:

cdlx_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_EntityInformationLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration